Development of the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with High Target Affinity and Tumor Accumulation by Substitution of the Chelating Moiety

Benutzer: Gast

Titel:: Development of the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with High Target Affinity and Tumor Accumulation by Substitution of the Chelating Moiety
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Günther, Thomas ; Holzleitner, Nadine ; Di Carlo, Daniel ; Urtz-Urban, Nicole ; Lapa, Constantin ; Wester, Hans-Jürgen
Stichworte:: Article ; cholecystokinin-2 receptor (CCK-2R) ; cholecystokinin-B receptor (CCK-BR) ; MTC ; radiohybrid ; rhCCK
Zeitschriftentitel:: Pharmaceutics
Jahr:: 2023
Band / Volume:: 15
Heft / Issue:: 3
Volltext / DOI:: doi:10.3390/pharmaceutics15030826
Verlag / Institution:: MDPI
E-ISSN:: 1999-4923
Publikationsdatum:: 03.03.2023
CC-Lizenz:: by, https://creativecommons.org/licenses/by/4.0

BibTeX

Vorkommen: